FDA announces new limits on high-dose simvastatin (Zocor)

June 9, 2011

The United States Food and Drug Administration (FDA) today announced new limitations to the use of high-dose simvastatin, due to the increased risk of muscle pain and weakness (myopathy) and in rare cases, kidney damage and failure.

The recommends that all and patients follow the FDA’s recommendations regarding high-dose .

Simvastatin is prescribed, along with a healthy diet and exercise to lower the low-density lipoprotein (LDL) cholesterol (“bad cholesterol”) in the blood, and to decrease the risk of heart attack, stroke, and cardiovascular death. It is used in doses ranging from 10 mg to 80 mg. per day.

The changes are based on the FDA’s recent review of the SEARCH trial, a seven-year, randomized double-blind clinical trial comparing patients with a previous heart attack taking 80 mg of simvastatin daily vs. 20 mg. daily. The trial found that the incidence of major vascular events was 25.7 percent for those taking 20 mg vs. 24.5 percent taking 80 mg. Approximately 52 patients in the study taking the 80 mg. dose experienced . About 60 percent of those experiencing myopathy had a genetic difference making it more likely.

A rare but serious form of myopathy, called rhabdomyolysis, can damage the kidneys and lead to potentially fatal kidney failure.

The American Heart Association supports the FDA recommendations for:

·        Patients who have taken the 80 mg. dose of simvastatin for a year or more without myopathy to remain on their current dose, unless recommended otherwise by their healthcare provider.
·        Patients with any symptoms of or weakness, dark or red urine, or unexplained tiredness to contact their healthcare provider immediately.
·        Patients taking 80 mg. of simvastatin for less than a year to talk to their provider about changing their dose, and not to discontinue their dose on their own.
·        Healthcare providers not to write new prescriptions for 80 mg. simvastatin or increase patients’ dosage to 80 mg.
·        Providers to reduce the dosage or try an alternative drug to lower LDL cholesterol for patients taking 80 mg. simvastatin daily for less than a year.

According to the FDA, in 2010, 2.1 million Americans were taking the 80 mg. dose of simvastatin.

Explore further: Schizophrenia misunderstood, psychiatrist says

Related Stories

Schizophrenia misunderstood, psychiatrist says

May 6, 2011

(Medical Xpress) -- Most people have heard the term "schizophrenia” and are aware that it’s a mental disorder. Unfortunately, a UC Health psychiatrist says, few people actually understand what schizophrenia is or ...

Recommended for you

Female smokers face greatest risk for brain bleeds

July 21, 2016

Bleeding inside the lining of the brain (subarachnoid hemorrhage) is significantly more common among smokers, especially female smokers, than among people who do not smoke, according to new research in the American Heart ...

Global study shows stroke largely preventable

July 15, 2016

Ten risk factors that can be modified are responsible for nine of 10 strokes worldwide, but the ranking of those factors vary regionally, says a study led by researchers of the Population Health Research Institute (PHRI) ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

dogbert
not rated yet Jun 09, 2011
The FDA would do better to ban statins entirely, but lowering the dosage of this statin is still a good thing.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.